APO RESEARCH · REPORT
Dydrogesterone Drug
Dydrogesterone is a progestin medication, which used for a variety of indications, including threatened or recurrent miscarriage during pregnancy, dysfunctional bleeding, infertility due to luteal insufficiency, dysmenorrhea, endometriosis, secondary amenorrhea, irregular cycles, premenstrual syndrome, and as a component of menopausal hormone therapy. It is taken by mouth.
Product & engineering
Understand the product.
Dydrogesterone is a progestin medication, which used for a variety of indications, including threatened or recurrent miscarriage during pregnancy, dysfunctional bleeding, infertility due to luteal insufficiency, dysmenorrhea, endometriosis, secondary amenorrhea, irregular cycles, premenstrual syndrome, and as a component of menopausal hormone therapy. It is taken by mouth.
Selected research
Industry Research
Dydrogesterone Drug Industry Research Report 2026
Market perspective
Dydrogesterone is a progestin medication, which used for a variety of indications, including threatened or recurrent miscarriage during pregnancy, dysfunctional bleeding, infertility due to luteal insufficiency, dysmenorrhea, endometriosis, secondary amenorrhea, irregular cycles, premenstrual syndrome, and as a component of menopausal hormone therapy. It is taken by mouth.
The classification of Dydrogesterone Drug includes Dydrogesterone and Dydrogesterone +Estradiol Compound, and the sale proportion of Dydrogesterone in 2019 is about 75.22%.
Dydrogesterone Drug is widely used for Infertility, Gynecological Diseases, Threatened Abortion, etc. The most proportion of Dydrogesterone Drug is used for Infertility, and the proportion in 2019 is 67.71%.
Read the full market overview
There are mainly two manufacturers in this industry, which is Abbott and Viatris，and their production are in Europe and USA respectively.
Asia-Pacific is the largest consumption place, with a consumption market share nearly 62.27% in 2019. Following Asia-Pacific, Europe is the second largest consumption place with the consumption market share of 15.77%.
Report Scope
This report quantifies the global Dydrogesterone Drug market in terms of revenue (US$ million) and, where applicable, sales volume (Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Dydrogesterone Drug Market by Company
Abbott
Viatris
Dydrogesterone Drug Segment by Type
Dydrogesterone
Dydrogesterone+Estradiol Compound
Dydrogesterone Drug Segment by Application
Infertility
Gynecological Diseases
Threatened Abortion
Other
Dydrogesterone Drug Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dydrogesterone Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dydrogesterone Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dydrogesterone Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Dydrogesterone Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Dydrogesterone Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Dydrogesterone Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Dydrogesterone
- Dydrogesterone+Estradiol Compound
Applications
- Infertility
- Gynecological Diseases
- Threatened Abortion
- Other
Companies covered
- Abbott
- Viatris
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Dydrogesterone Drug Market Size (2021-2032)
- 2.2.2 Global Dydrogesterone Drug Sales (2021-2032)
- 2.2.3 Global Dydrogesterone Drug Market Average Price (2021-2032)
- 2.3 Dydrogesterone Drug by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Dydrogesterone
- 2.3.3 Dydrogesterone+Estradiol Compound
- 2.4 Dydrogesterone Drug by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Infertility
- 2.4.3 Gynecological Diseases
- 2.4.4 Threatened Abortion
- 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Dydrogesterone Drug Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Dydrogesterone Drug Sales (Units) of Manufacturers (2021-2026)
- 3.3 Global Dydrogesterone Drug Revenue of Manufacturers (2021-2026)
- 3.4 Global Dydrogesterone Drug Average Price by Manufacturers (2021-2026)
- 3.5 Global Dydrogesterone Drug Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Dydrogesterone Drug, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Dydrogesterone Drug, Product Type & Application
- 3.8 Global Manufacturers of Dydrogesterone Drug, Established Date
- 3.9 Global Dydrogesterone Drug Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Abbott
- 4.1.1 Abbott Company Information
- 4.1.2 Abbott Business Overview
- 4.1.3 Abbott Dydrogesterone Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Abbott Dydrogesterone Drug Product Portfolio
- 4.1.5 Abbott Recent Developments
- 4.2 Viatris
- 4.2.1 Viatris Company Information
- 4.2.2 Viatris Business Overview
- 4.2.3 Viatris Dydrogesterone Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Viatris Dydrogesterone Drug Product Portfolio
- 4.2.5 Viatris Recent Developments
5 Global Dydrogesterone Drug Market Scenario by Region
- 5.1 Global Dydrogesterone Drug Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Dydrogesterone Drug Sales by Region: 2021-2032
- 5.2.1 Global Dydrogesterone Drug Sales by Region: 2021-2026
- 5.2.2 Global Dydrogesterone Drug Sales by Region: 2027-2032
- 5.3 Global Dydrogesterone Drug Revenue by Region: 2021-2032
- 5.3.1 Global Dydrogesterone Drug Revenue by Region: 2021-2026
- 5.3.2 Global Dydrogesterone Drug Revenue by Region: 2027-2032
- 5.4 North America Dydrogesterone Drug Market Facts & Figures by Country
- 5.4.1 North America Dydrogesterone Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Dydrogesterone Drug Sales by Country (2021-2032)
- 5.4.3 North America Dydrogesterone Drug Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Dydrogesterone Drug Market Facts & Figures by Country
- 5.5.1 Europe Dydrogesterone Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Dydrogesterone Drug Sales by Country (2021-2032)
- 5.5.3 Europe Dydrogesterone Drug Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Dydrogesterone Drug Market Facts & Figures by Country
- 5.6.1 Asia Pacific Dydrogesterone Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Dydrogesterone Drug Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Dydrogesterone Drug Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Dydrogesterone Drug Market Facts & Figures by Country
- 5.7.1 South America Dydrogesterone Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Dydrogesterone Drug Sales by Country (2021-2032)
- 5.7.3 South America Dydrogesterone Drug Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Dydrogesterone Drug Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Dydrogesterone Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Dydrogesterone Drug Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Dydrogesterone Drug Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Dydrogesterone Drug Sales by Type (2021-2032)
- 6.1.1 Global Dydrogesterone Drug Sales by Type (2021-2032) & (Units)
- 6.1.2 Global Dydrogesterone Drug Sales Market Share by Type (2021-2032)
- 6.2 Global Dydrogesterone Drug Revenue by Type (2021-2032)
- 6.2.1 Global Dydrogesterone Drug Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Dydrogesterone Drug Revenue Market Share by Type (2021-2032)
- 6.3 Global Dydrogesterone Drug Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Dydrogesterone Drug Sales by Application (2021-2032)
- 7.1.1 Global Dydrogesterone Drug Sales by Application (2021-2032) & (Units)
- 7.1.2 Global Dydrogesterone Drug Sales Market Share by Application (2021-2032)
- 7.2 Global Dydrogesterone Drug Revenue by Application (2021-2032)
- 7.2.1 Global Dydrogesterone Drug Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Dydrogesterone Drug Revenue Market Share by Application (2021-2032)
- 7.3 Global Dydrogesterone Drug Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Dydrogesterone Drug Value Chain Analysis
- 8.1.1 Dydrogesterone Drug Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Dydrogesterone Drug Production Mode & Process
- 8.2 Dydrogesterone Drug Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Dydrogesterone Drug Distributors
- 8.2.3 Dydrogesterone Drug Customers
9 Global Dydrogesterone Drug Analyzing Market Dynamics
- 9.1 Dydrogesterone Drug Industry Trends
- 9.2 Dydrogesterone Drug Industry Drivers
- 9.3 Dydrogesterone Drug Industry Opportunities and Challenges
- 9.4 Dydrogesterone Drug Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst